Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis

BACKGROUND: Antithrombotic (anticoagulant or antiplatelet) therapy is withheld from some patients with cerebral cavernous malformations, because of uncertainty around the safety of these drugs in such patients. We aimed to establish whether antithrombotic therapy is associated with an increased risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuurbier, Susanna M, Hickman, Charlotte R, Tolias, Christos S, Rinkel, Leon A, Leyrer, Rebecca, Flemming, Kelly D, Bervini, David, Lanzino, Giuseppe, Wityk, Robert J, Schneble, Hans-Martin, Sure, Ulrich, Al-Shahi Salman, Rustam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Pub. Group 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744367/
https://www.ncbi.nlm.nih.gov/pubmed/31401075
http://dx.doi.org/10.1016/S1474-4422(19)30231-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744367/
https://www.ncbi.nlm.nih.gov/pubmed/31401075
http://dx.doi.org/10.1016/S1474-4422(19)30231-5

Ejemplares similares